Medical-device company making biomaterial-based hemostat and wound-care products.
| Date | Round | Amount |
|---|---|---|
| Jul 2021 | Series B Medtech Axio Biosolutions raised a $6M Series B2 led by TrueScale Capital. | $6M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.